AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines

AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines

Abstract Background Small cell lung cancer (SCLC) is a neuroendocrine tumor with poor prognosis. Neuroendocrine tumors possess characteristics of both nerve cells and hormone‐secreting cells; therefore, targeting the neuronal properties of these tumors may lead to the development of new therapeutic...

Full description

Bibliographic Details
Main Authors: Nami Masumoto, Shingo Kato, Masahiro Aichi, Sho Hasegawa, Kota Sahara, Kumiko Suyama, Akane Sano, Tomoyuki Miyazaki, Koji Okudela, Takeshi Kaneko, Takuya Takahashi
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Thoracic Cancer
Subjects:
AMPAR
cyanquixaline
small cell lung cancer
talampanel
α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid receptor
Online Access:https://doi.org/10.1111/1759-7714.15075

Internet

https://doi.org/10.1111/1759-7714.15075

Similar Items